Senthilmurugan Ramalingam

Somatic <i>SLC35A2</i> variants in the brain are associated with intractable neocortical epilepsy

Melodie R. Winawer, Nicole G. Griffin, Jorge Samanamud et al. · Annals of Neurology · 2018 · 135 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer

Puranik Purushottamachar, Abhijit M. Godbole, Lalji K. Gediya et al. · Journal of Medicinal Chemistry · 2013 · 103 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts<i>in vivo</i>

Andrew K. Kwegyir‐Afful, Senthilmurugan Ramalingam, Puranik Purushottamachar et al. · Oncotarget · 2015 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines

Senthilmurugan Ramalingam, Lalji K. Gediya, Andrew K. Kwegyir‐Afful et al. · Oncotarget · 2014 · 56 citations · Full text

Life Sciences, Oncology, Pharmacology +15

The retinamide <scp>VNLG</scp>‐152 inhibits <scp>f‐AR</scp>/<scp>AR</scp>‐V7 and <scp>MNK</scp>–<scp>eIF</scp>4E signaling pathways to suppress <scp>EMT</scp> and castration‐resistant prostate cancer xenograft growth

Vidya P. Ramamurthy, Senthilmurugan Ramalingam, Lalji K. Gediya et al. · FEBS Journal · 2018 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +17